HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myotonia congenita and myoadenylate deaminase deficiency: case report.

Abstract
Approximately 1-2% of the population has a deficiency of the enzyme myoadenylate deaminase. Early reports suggested that patients with myoadenylate deaminase deficiency had various forms of myalgia, and exercise intolerance. However, a deficiency of the enzyme has been described in many conditions, including myopathies, neuropathies, and motor neuron disease. We report a patient with clinical diagnosis of myotonia congenita and absent myoadenylate deaminase reaction on the muscle biopsy. This is the first description of myoadenilate deaminase deficiency with myotonia congenita. Myoadenylate deaminase deficiency is the most common enzymatic deficit of muscle, and the association with other neuromuscular diseases is coincidental.
AuthorsRosana Herminia Scola, Fabio Massaiti Iwamoto, Carlos Henrique Camargo, Walter Oleschko Arruda, Lineu Cesar Werneck
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 61 Issue 2A Pg. 262-4 (Jun 2003) ISSN: 0004-282X [Print] Germany
PMID12806508 (Publication Type: Case Reports, Journal Article)
Chemical References
  • AMP Deaminase
Topics
  • AMP Deaminase (deficiency)
  • Biopsy
  • Child
  • Humans
  • Male
  • Muscle, Skeletal (enzymology, pathology)
  • Myotonia Congenita (enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: